These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36123895)

  • 1. SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics.
    Xu K; Wu Y; Chi H; Li Y; She Y; Yin X; Liu X; He B; Li X; Du H
    Medicine (Baltimore); 2022 Sep; 101(37):e30270. PubMed ID: 36123895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
    Cui Y; Zhou Z; Chai Y; Zhang Y
    J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma.
    Xie C; Yiu W; Mo Y
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.
    Gao J; Ye F; Han F; Jiang H; Zhang J
    Front Immunol; 2022; 13():956679. PubMed ID: 36177018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
    Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J
    Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cuproptosis-related gene
    Wang T; Liu Y; Li Q; Luo Y; Liu D; Li B
    Front Immunol; 2022; 13():999823. PubMed ID: 36225932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
    Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
    Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
    Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
    Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
    Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma.
    Long Q; Huang C; Huang J; Meng Q; Cheng Y; Li Y; He L; Chen M; Zhang C; Wang X; Zhu W; Peng J; Shi D; Zheng F; Dong P; Deng W
    J Adv Res; 2022 Sep; 40():153-166. PubMed ID: 36100323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential biomarkers for progression and prognosis of renal clear cell carcinoma by comprehensive bioinformatics analysis.
    Dong H; He Z; Wang H; Ding M; Huang Y; Li H; Shi H; Mao L; Hu C; Wang J
    Technol Health Care; 2024; 32(2):897-914. PubMed ID: 37483037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of
    Wang T; Xie F; Li YH; Liang B
    Future Oncol; 2021 Dec; 17(36):5033-5044. PubMed ID: 34704468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.
    Meng W; Chen B; Jiang Z; Cai B; Ma L; Guan Y
    Transl Cancer Res; 2023 Aug; 12(8):2071-2098. PubMed ID: 37701098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma.
    Zhao J; Pan X; Wang Z; Chen Y; Liu D; Shen Y; Wei X; Xu C; Zhang X; Hu X; Chen J; Zhao J; Tang B; Sun G; Shen P; Liu Z; Zeng H; Liang J
    Eur J Med Res; 2024 Jul; 29(1):378. PubMed ID: 39033192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry.
    Han D; Yu Z; Zhang H; Liu H; Wang B; Qian D
    Bioengineered; 2021 Dec; 12(2):10891-10904. PubMed ID: 34845968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
    Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
    Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
    Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
    Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis.
    Al Sharie AH; Abu Zahra AM; El-Elimat T; Darweesh RF; Al-Khaldi AK; Abu Mousa BM; Amer MSB; Al Zu'bi YO; Al-Kammash K; Abu Lil A; Al Malkawi AA; Alazzeh Z; Alali FQ
    Medicine (Baltimore); 2023 Sep; 102(36):e35004. PubMed ID: 37682177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.